The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicity.

N. S. Prabhu, K. Somasundaram, H. Tian, G. H. Enders, K. Satyamoorthy, M. Herlyn, W. S. El-Deiry

    Research output: Contribution to journalArticlepeer-review

    14 Citations (Scopus)

    Fingerprint Dive into the research topics of 'The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicity.'. Together they form a unique fingerprint.

    Medicine & Life Sciences